Eikon Therapeutics, Inc. EIKN
- IMP1734 — Ovarian Cancer Phase 1
- IMP1734 — Breast Cancer Phase 1
- IMP1734 — Prostate Cancer Phase 1
- IMP1734 — Pancreatic Cancer Phase 1
- IMP1707 — Ovarian Cancer Phase 1
- IMP1707 — Breast Cancer Phase 1
- IMP1707 — Prostate Cancer Phase 1
- IMP1707 — Pancreatic Cancer Phase 1
- EIK1004 — Brain Metastases Phase 1